Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -187,865 | -102,937 | -81,622 | -46,519 | -95,357 |
| Depreciation Amortization | 4,975 | 4,963 | 1,440 | 221 | 7,878 |
| Income taxes - deferred | 4,341 | 2,093 | -2,003 | N/A | -146 |
| Accounts receivable | 8,970 | -9,799 | 818 | N/A | -11,048 |
| Accounts payable and accrued liabilities | 1,380 | 4,547 | 553 | 283 | 533 |
| Other Working Capital | 19,242 | -5,862 | -8,422 | -345 | 730 |
| Other Operating Activity | 31,476 | 4,251 | 33,388 | 32,772 | 28,651 |
| Operating Cash Flow | $-117,481 | $-102,744 | $-55,848 | $-13,588 | $-68,759 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,653 | -1,611 | -647 | -758 | -2,324 |
| Purchase Of Investment | -299,182 | -232,343 | -16,590 | N/A | -226,953 |
| Sale Of Investment | 200,842 | 121,315 | 52,000 | N/A | 268,684 |
| Other Investing Activity | 0 | 0 | 74,909 | 0 | 0 |
| Investing Cash Flow | $-99,993 | $-112,639 | $109,672 | $-758 | $39,407 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -47 | -79 | N/A |
| Common Stock Issued | 159,218 | 209,524 | 109,860 | 17 | 1,986 |
| Other Financing Activity | -7,786 | 0 | 14,479 | 25,748 | -3,481 |
| Financing Cash Flow | $151,432 | $209,524 | $124,292 | $25,686 | $-1,495 |
| Exchange Rate Effect | -244 | 157 | 27 | 17 | -457 |
| Beginning Cash Position | 183,798 | 189,500 | 11,357 | N/A | 158,082 |
| End Cash Position | 117,512 | 183,798 | 189,500 | 11,357 | 126,778 |
| Net Cash Flow | $-66,286 | $-5,702 | $178,143 | $11,357 | $-31,304 |
| Free Cash Flow | |||||
| Operating Cash Flow | -117,481 | -102,744 | -55,848 | -13,588 | -68,759 |
| Capital Expenditure | -1,653 | -1,878 | -797 | -758 | -2,365 |
| Free Cash Flow | -119,134 | -104,622 | -56,645 | -14,346 | -71,124 |